The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 11, 2025

Filed:

Oct. 31, 2018
Applicant:

Novo Nordisk A/s, Bagsvaerd, DK;

Inventors:

Christian Peter Enggaard, Vejby, DK;

Rune Ravn, Hasaselager, DK;

Assignee:

Novo Nordisk A/S., Bagsvaerd, DK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16H 20/17 (2018.01); A61M 5/315 (2006.01); G16H 40/67 (2018.01); A61M 5/31 (2006.01);
U.S. Cl.
CPC ...
G16H 20/17 (2018.01); A61M 5/31535 (2013.01); A61M 5/31546 (2013.01); A61M 5/3159 (2013.01); G16H 40/67 (2018.01); A61M 2005/3125 (2013.01); A61M 5/31571 (2013.01); A61M 5/31573 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/50 (2013.01); A61M 2205/581 (2013.01); A61M 2205/582 (2013.01); A61M 2205/583 (2013.01);
Abstract

The present invention provides a system () comprising: a pen injection device () holding a specific type of medicament and comprising a dose expelling mechanism and pen communication means (), a mobile communication unit () comprising mobile communication means () adapted to communicate with the pen communication means (), and a software application program configured to determine a recommended type of medicament to be delivered to a user based on information indicative of a physiological condition of the user, wherein the pen injection device () further comprises indication means which in a first state indicates that the dose expelling mechanism is to remain idle and in a second state indicates that the dose expelling mechanism is available for operation, and wherein the mobile communication unit () is configured to, via a communication from the mobile communication means () to the pen communication means (), a) prompt a change of state of the indication means from the second state to the first state in response to the recommended type of medicament to be delivered differing from the specific type of medicament, and/or b) prompt a change of state of the indication means from the first state to the second state in response to the recommended type of medicament to be delivered corresponding to the specific type of medicament.


Find Patent Forward Citations

Loading…